Avelo
Avelo’s device makes the diagnosis of respiratory infections easier and more reliable.
Avelo has raised €2.4M across 2 funding rounds from 5 investors, most recently a Seed round in Sep 2022. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Zurich, Switzerlandwww.avelolife.com ↗
Total raised
€2.4M
€2,428,951
Funding rounds
2
Investors
5
distinct backers
Active since
2022-06
latest 2022-09
Funding by year
EUR raised per yearAvelo — funding by year — interactive chart.
Data table
| Avelo — funding by year | |
|---|---|
| 2022 | €2.4M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-20 | Seed | €2.3M | Angel Investors,Arve Capital,OCCIDENT,Privilège Ventures,Zürcher Kantonalbank | View deal → |
| 2022-06-22 | Other | €148k | — | View deal → |
Investors
5Related news
- Avelo closes CHF 2.2 million oversubscribed seed roundstartupticker.ch · 2022-09
- Avelo wins CHF 150,000 to improve respiratory disease diagnosesstartupticker.ch · 2022-06
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData